title: Atypical lymphocytes in B-cell chronic lymphocytic leukemia and trisomy 12 studied by conventional staining combined with fluorescence in situ hybridization.
abstract: Trisomy 12 is one of the most frequent chromosomal abnormalities in B-cell chronic lymphocytic leukemia (CLL), and is predominantly found in CLL with atypical morphology (aCLL). It has been suggested that the atypical morphology might be a feature of the abnormal trisomy 12 clone, but so far it has been difficult to allocate chromosomal aberrations to individual leukemic cells identified by cytomorphology. We therefore wanted to use our MGG/FISH method, which combines fluorescence in situ hybridization (FISH) and standard cytomorphology, to study if the trisomy 12 clone in CLL was restricted to lymphocytes with atypical morphology. Peripheral blood specimens of four patients with aCLL were studied using a DNA probe against the pericentromeric region of chromosome 12. Trisomy 12 was found in 10-34 % of the lymphocytes. In three patients, the proportion of atypical and typical lymphocytes with trisomy 12 was quite comparable, and so was the percentage of atypical cells with lymphoplasmacytoid morphology and those with cleaved nucleus showing trisomy 12. Only one patient differed, since we found an overrepresentation of trisomy 12 among the atypical lymphocytes. However, this could be fully explained by the diluting effect of contaminating T-cells after chemotherapy. The results of the present study show that despite the strong association of trisomy 12 and atypical morphology in CLL, this chromosomal abnormality is not confined to lymphocytes with atypical morphology, but is also found in typical CLL cells. This supports that both cell types have the same clonal origin and that different cell morphology cannot be explained alone by the acquisition of an additional chromosome 12.
authors.affiliation: Division of Hematology, Department of Medicine, Karolinska Hospital, Karolinska Institutet, Stockholm, Sweden. viktoria.hjalmar@kids.ki.se
authors.forename: V
authors.initials: V
authors.lastname: Hjalmar
authors.forename: E
authors.initials: E
authors.lastname: Kimby
authors.forename: E
authors.initials: E
authors.lastname: Matutes
authors.forename: C
authors.initials: C
authors.lastname: Sundström
authors.forename: J
authors.initials: J
authors.lastname: Wallvik
authors.forename: R
authors.initials: R
authors.lastname: Hast
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001402:B-Lymphocytes / Q000473:pathology*; D002467:Cell Nucleus / Q000648:ultrastructure; D002881:Chromosomes, Human, Pair 12; D004396:Coloring Agents; D004801:Eosine Yellowish-(YS); D005260:Female; D006801:Humans; D016130:Immunophenotyping; D017404:In Situ Hybridization, Fluorescence; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000235:genetics / Q000473:pathology*; D008297:Male; D008751:Methylene Blue; D008875:Middle Aged; D014411:Neoplastic Stem Cells / Q000473:pathology; D013194:Staining and Labeling / Q000379:methods*; D014314:Trisomy
chemical_list: D004396:Coloring Agents; C043260:May-Grunwald Giemsa; D008751:Methylene Blue; D004801:Eosine Yellowish-(YS)